Myriad Genetics to Release Fourth-Quarter Financial Results
SALT LAKE CITY, Feb. 22, 2023 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in genetic testing
Globe Newswire22-02-2023, 19:06
Teva Announces Agreement to Divest Teva-Takeda, its Business Venture in Japan 6-12-2024, 06:00